Bioventus (BVS) Receivables (2020 - 2025)
Historic Receivables for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $133.3 million.
- Bioventus' Receivables rose 154.07% to $133.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.3 million, marking a year-over-year increase of 154.07%. This contributed to the annual value of $130.3 million for FY2024, which is 241.07% up from last year.
- As of Q3 2025, Bioventus' Receivables stood at $133.3 million, which was up 154.07% from $135.3 million recorded in Q2 2025.
- Bioventus' 5-year Receivables high stood at $158.5 million for Q4 2021, and its period low was $93.3 million during Q2 2021.
- Its 5-year average for Receivables is $129.3 million, with a median of $128.7 million in 2024.
- Its Receivables has fluctuated over the past 5 years, first skyrocketed by 4118.31% in 2022, then crashed by 1455.78% in 2023.
- Over the past 5 years, Bioventus' Receivables (Quarter) stood at $128.4 million in 2021, then rose by 11.78% to $143.6 million in 2022, then dropped by 11.37% to $127.3 million in 2023, then rose by 2.41% to $130.3 million in 2024, then grew by 2.25% to $133.3 million in 2025.
- Its Receivables was $133.3 million in Q3 2025, compared to $135.3 million in Q2 2025 and $120.9 million in Q1 2025.